Pot-Like Compound May Slow Alzheimer's
Tests on Rats Show Less Brain Inflammation, Better Memory With Synthetic Pot
WebMD News Archive
Oct. 19, 2006 -- A marijuana-like compound may cut brain inflammation and slow the progression of Alzheimer's disease, scientists report.
The compound is a synthetic cannabinoid, made in a lab to resemble marijuana.
Old rats given the compound performed better in a maze, according to research by Gary Wenk, PhD, professor of psychology and neuroscience at Ohio State University, and others.
What about people? "Now, I don't know, because I'm just a rat guy, whether this is going to work that well in humans," Wenk tells WebMD. "But it looks like it will, because of what we've seen with other drugs in other diseases."
The marijuana-like drug "won't cure the disease, but what it might do is stop the processes that are involved in making the disease worsen," Wenk says. "I think that's the most exciting aspect."
"What may matter is that we can tell people that we might be able to step in, stop the inflammation, and they might die of old age before the inflammation has a chance to rebuild itself, which we believe takes many decades," Wenk says.
"That's the main hope, I think," he says.
Reducing Brain Inflammation
Wenk's team tested the synthetic cannabinoid to curb brain inflammation in rats.
"We know that brain inflammation at a low level plays a role in lots of diseases" including Alzheimer's, Wenk explains.
"Now inflammation in all these conditions doesn't cause the disorder," he says. But, "it has consequences."
"In fact, the inflammation appears long before plaques and tangles and memory impairment," Wenk says, referring to the plaques and tangles seen in the brains of people who die with Alzheimer's disease.